Proton therapy improves neurocognitive outcomes of childhood craniopharyngioma
In a recent phase 2 clinical trial for children with craniopharyngioma, researchers at St. Jude found that photon therapy and the more targeted proton therapy resulted in similar survival, but patients who received proton therapy had a better neurocognitive outcome than those who received photon therapy. This clinical trial may set the new “gold standard” for pediatric craniopharyngioma treatment.
Comments